Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10

• Because of its immunosuppressive properties, interleukin-10 (IL-10) is thought to play an important role in a number of human disease states, including inflammation, autoimmunity, and transplant rejection. In this study, we demonstrate that introduction of human or viral IL-10 genes into Burkitt's lymphoma cells markedly reduced their ability to grow as subcutaneous (sc) tumors in SCID mice. In vivo assays for angiogenesis revealed an inhibition of the angiogenic capacity of the IL-10-transfected lines. Recombinant human IL-10 abolished and viral IL-10 reduced vascular endothelial growth factor (VEGF)-165-induced neovascularization. Furthermore, IL-10 blocked the VEGF- and fibroblast growth factor (FGF)-2-induced proliferation of microvascular endothelial cells in vitro. The current observations suggest a direct role for IL-10 in the prevention of angiogenesis in human lymphoid malignancies.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Animals

Burkitt Lymphoma

Cell Division

Cell Line

Endothelial Growth Factors

Endothelium, Vascular

Fibroblast Growth Factor 2

Gene Expression

Interleukin-10

Killer Cells, Natural

Lymphokines

Mice

Mice, SCID

Neoplasm Transplantation

Neovascularization, Pathologic

Rabbits

Recombinant Proteins

Transfection

Tumor Cells, Cultured

Vascular Endothelial Growth Factor A

Vascular Endothelial Growth Factors

Publikations- och innehållstyp

art (ämneskategori)

ref (ämneskategori)